The modulation of REST/NRSF, its target gene SNAP-25 and BDNF expression by mGluR5 NAM may therefore represent a novel pharmacological tool to halt the progression of HD and potentially other neurodegenerative diseases. The gene discussed is REST; the disease is Huntington disease.